At-Home HPV test could revolutionize cervical cancer screening
NCT ID NCT05600283
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether women can collect their own vaginal samples to detect HPV, the virus that causes cervical cancer. Researchers compared self-collected swabs to those taken by a doctor in 222 participants. The goal was to see if self-sampling is accurate and acceptable, which could make screening easier and more accessible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUMAN PAPILLOMA VIRUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic Minnesota
Rochester, Minnesota, 55905, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could HPV shots start earlier? study tests vaccine in kids as young as 4
- Immune cell therapy takes on HPV
- ERs may soon offer At-Home HPV tests to reach women who skip screenings
- Could a common numbing drug help fight throat cancer?
- New program aims to protect HIV patients from HPV cancer
- New cream could fight HPV lesions in HIV patients